Briefing to Member States Information under embargo

Slides:



Advertisements
Similar presentations
Prison staff and harm reduction Additional module: Foreign prisoners Training Criminal Justice Professionals in Harm Reduction Services for Vulnerable.
Advertisements

Supporting community action on AIDS in developing countries Supporting community action on AIDS in India Children Affected By AIDS in Low and Concentrated.
Robin Pollard Operations Coordinator Youth RISE.
Krzysztof Krajewski Jagiellonian University Department of Criminology Krakow - Poland Gaps in the knowledge base – evidence in the criminal justice system.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Extreme poverty and vulnerability in OECD countries Dominic Richardson How to measure Extreme Poverty in the EU Brussels 22 nd September 2009.
Professor Eddie Kane.
ACHMA 2012 Summit Healthy Supports, Healthy Communities: Improving the Health of Communities Through Social Supports.
Exploring the future role of services Dave Liddell.
Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.
Advanced Briefing to Member States
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Inclusion of Adolescents with Disabilities: Towards an AIDS-Free Generation All In! Rosangela Berman Bieler Senior Adviser, Children with Disabilities,
The World’s Biggest Minority Left Behind: National HIV-Responses Need to and Can Include Disability Towards a UNAIDS Disability Strategy Ruben Mayorga.
BY TANYA MARIA GOLASH-BOZA Chapter Eleven: Racism and the Criminal Justice System.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
Drug treatment in prisons: recent evidence Jessica Harris, RDS NOMS, Home Office Malcolm Ramsay, DSPD Programme, Home Office.
Improving health and protecting human rights Improving health and protecting human rights for individuals, communities, and society Harm reduction and.
Agenda 4 AGENDA 4: ALTERNATIVES TO IMPRISONMENT. Canada Fiji India (Bihar, Andhra Pradesh, Tamil Nadu) Malaysia Experiences shared by: Thailand Brunei.
Key priorities, challenges and opportunities to advance the agenda for children in middle income countries of CIS, Eastern and Southern Europe Yuri Oksamitniy.
Sexual Offender Treatment in Estonia: the Current Situation and Future Perspective Kaire Tamm Ministry of Justice of Estonia Criminal Policy Department.
HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.
Dr Fabienne Hariga Senior Adviser UNODC HIV Section, Vienna 27 May 2014 Mandates, missions, roles and responsibilities & relation to health in prisons.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.
A Probation perspective for International women’s day events, March 2013.
Nino Maddalena Criminal Justice Manager National Treatment Agency.
A multi-disciplinary theory of drug-related harm reduction
Annual report 2010: the state of the drugs problem in Europe.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
Elaine Stalker Why families need additional support Edinburgh Corn Exchange 3 October 2012 Family Matters ‘He’s doing the sentence, but I’m paying the.
Peter Sarosi Hungarian Civil Liberties Union (HCLU) Dialogoue on Drug Policy 8 June, European and Hungarian drug policies: based on evidence?
Addressing Substance Use Disorders Translating Science To Policy In The 2010 Drug Control Strategy.
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
UPR Thailand 2011 – HIV Affected Women and Girls NASHIDA SATTAR POLICY AND PROGRAMME SPECIALIST HIV, HEALTH AND GENDER EQUALITY UNDP, BANGKOK REGIONAL.
THE SCALE OF THE PROBLEM Quaker penal reform seminar 2013.
Salford’s Alcohol Strategy Background Salford’s Drug and Alcohol Strategy Safe. Sensible. Social. : next steps in the national alcohol.
Meeting of Caribbean National Drug Observatories CICAD Programme to Estimate the Human Social and Economic Cost of Drugs in the Americas (Cost Programme)
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
WJCIA It’s September 2009: Do You Know Where Your 17-Year Old Is? WJCIA Fall 2009 Jim Moeser Wisconsin Council on Children and Families.
Criminal Justice Reform Brussels, 18 June 2013 Katarina MOTOSKOVA DEVCO B1 –Governace Democracy Human Rights and Gender EuropeAid Development and Co-operation.
04/06/2016Presentation name104/06/2016Presentation name1 Adult Drug Misuse Kerry Anderson – Modernisation Manager, Public Health.
Prison Reforms - UNODC perspective Dr. Jayadev Sarangi, Prison Expert UNODC ROSA APCCA,2008 Langkawi, Malaysia, 24th November 2008.
2011 Global Study on Homicide Washington DC October 18th, 2011 Enrico Bisogno Team Leader Crime Statistics UNODC.
Soc 326 – Chap 14 The “new community focus” -- focuses on communities/neighborhoods focuses on communities/neighborhoods Note: remember the Consumer Union.
Disability, poverty and livelihoods. General figures…  10% - 12% of the world’s population has some form of disabling impairment (over 600 million people)
The Effects of Imprisonment on Female Offenders Annetta Bennett Consultant Safeguarding Specialist.
Youth Criminal Justice Act. to prevent youth crime to have meaningful consequences and ensure accountability for youth crime to improve rehabilitation.
Sam Tearle Service Development Manager West Sussex Drug Alcohol Action Team.
Citywide Drugs Crisis Campaign 20 years experience of Community Involvement – Key Lessons for the next National Drugs Strategy 12 TH NOVEMBER 2015.
1 Background & history of the debate Geneva, 14 October 2009 Ralf Jürgens.
Evaluating screening and brief intervention in a criminal justice setting Adrian Barton & Greta Squire School of Law and Social Science University of Plymouth.
HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.
An Assessment of Causative and Risk factors leading to Recidivism: A Case study of the Matsapha Correctional Services -Swaziland By Mr. Sibusiso Mahlalela.
How can annual reports help in ensuring gender responsive budgeting? Joint Monitoring Committee on Improvement of Quality of Life & Status of Women 16.
First European conference on drug supply indicators, , Brussels – Feed-back Chloé Carpentier, Laurent Laniel, EMCDDA 33 rd meeting of the.
…Implications for Wales Josie Smith Programme Lead for Substance Misuse, Public Health Wales TOWARDS A HEALTH BASED APPROACH.
PREVENTION OF DRUG ABUSE AMONG VULNERABLE GROUPS Dr Marcus Roberts Director of Policy and Membership DRUGSCOPE.
Recidivism Rates for DCJ Offenders Exiting Residential Treatment June 2007 Kim Pascual Research & Evaluation.
Drug-related deaths Phil Conley Health Improvement Programme Manager September 2015.
The effectiveness and cost-effectiveness of alcohol control policies PHE Evidence Review 31st January 2017.
Recidivism Rates for DCJ Offenders Exiting Residential A&D Treatment
Youth Justice: A balanced approach
Access Equity in Prisons in Africa A CALL FOR ACTION
World Drug Report June 2015.
Towards a Conducive Legal and Structural Environment
Briefing to Member States Information under embargo
IMPROVING SCOTLAND’S HEALTH Rights, Respect and Recovery
Mexico´s contribution to a public-health based approach to drug use at the multilateral level
Presentation transcript:

Briefing to Member States Information under embargo World Drug Report 2016 Briefing to Member States 16 June 2016 Information under embargo until 23 June 2016

Overall prevalence of illicit drug use has remained rather stable in recent years, affecting around 5.2% of the population age 15-64.

Global average: 43.5 Total: 207,400

Proportion of women brought into formal contact with the criminal justice system for drug related offences, 1998-2014 Number of women arrested for drug-related offences increased, but the proportion of women in drug-related cases decreased While 1 in 3 persons using drugs worldwide is a women, the proportion of women in formal contact with the criminal justice system for drug-related offences has been far smaller; around 10% over the 2009-2014 period (11 per cent for drug trafficking and 9% for drug possession related offences). The proportion of women arrested for drug trafficking offences has even declined between 1998 and 2014. The proportion of female arrests for drug trafficking over the 2009-2014 period has been above average for sedatives and tranquilisers (i.e. substances often used by women) as well as for opioids, amphetamine-type stimulants and, to a lesser extent for NPS and cocaine. In contrast, the female proportion of cannabis related offences was below average.

Trafficking over the internet, notably via the darknet, has increased strongly in recent years. A global survey of more than 100,000 Internet users (three quarters of whom had taken illegal drugs) in 50 countries in late 2014 suggested that the proportion of drug users purchasing drugs via the Internet had increased from just 1.2 per cent in 2000 to 4.9 per cent in 2009, 16.4 per cent in 2013 and 25.3 per cent in 2014. The proportion of Internet users making use of the “dark net” for drug purchases had also increased, reaching 6.4 per cent (lifetime) in 2014, including 4.5 per cent (70 per cent of 6.4 per cent) who had purchased drugs over the “dark net” in the previous 12 months. Among “recent” drug users, the proportion rose by more than 25 per cent from 2013 to 2014 (from 4.6 to 5.8 per cent). In some countries, including Australia and the United Kingdom, the proportion of recent years making use of the darknet for their drug purchases more than doubled between 2012 and 2014. The survey found that ecstasy was very often purchased via the darknet, as well as LSD, cannabis and cocaine. Purchases of heroin or methamphetamine via the darknet, in contrast, were less common. Some of those advantages for purchasing drugs via the darknet were related to the drug products themselves, which were reported to be generally of better quality and more readily available. Other advantages included the fact that the purchaser’s interactions were virtual, thus decreasing the risk to personal safety during transactions, including through the absence of exposure to physical violence; in addition, there was a perceived decrease in the risk of being apprehended by law enforcement authorities. This may help explain why, in general, drug users seem ready to pay a premium for drugs purchased via the “dark net” and why people who have never previously used drugs may be tempted to purchase them online. Around 4 per cent of “dark net” drug users had not used any drugs prior to accessing them through the “dark net”. At the same time, 30 per cent of people who purchased drugs via the “dark net” reported having consumed a wider range of drugs than they did before they began purchasing drugs via the “dark net

Polydrug use Injecting practices

Interception rates on the rise The interception rate of opiates doubled following the 1998 UNGASS.

Opiate production and consumption fluctuations Opium production is characterized by strong annual fluctuations. In 2015 global opium production declined by almost 40%. Heroin seizures and heroin consumption, contrast, appear to be far more stable. The WDR analyzed a number of hypotheses. Consumers can react to changes in supply by either increasing or decreasing per capita consumption or the total number of consumers may change. Some adjustments may take this form. The most important adjustment to changes in opium production, however, appear to be changes in opium inventories. Once there is a surplus, opium is stocked, and once there has been a poor opium harvest, opium accumulated from previous years is used for heroin production. This allows for a rather smooth production of heroin and supply of heroin to the consumer markets. This means, however, also that despite of the almost 40% decline in opium production in 2015 no immediate heroin shortage on the markets should be expected. There would be a need for a sustained decline in global opium production in order to really see an impact on the heroin markets.

Long and short term fluctuation in cocaine use Houshold survey data for Europe also show decline over the 2006-2014 period, including a rather stable situation over the 2011-2014 period. The overall stable patterns in recent years are also reflected in the analysis of waste-water data (based on the analysis of benzoylecgonine, one of the main cocaine metabolites) across 67 European cities over the 2011-2014 period. At the same time, the data also show important differences in the amounts of cocaine consumed in various cities. Important differences of benzoylecgonine (and thus in cocaine consumption) are not only found across countries but often also within different cities located in the same country.

One of the problematic developments in recent years has been the growing market for ‘captagon’ tables in the Middle East. Captagon used to be phenetylline though over the last decade tablets containing amphetamine mixed with caffeine is sold in illicit markets in the Near and Middle east under the name of captagon. For many years captagon was produced in South-East Europe, including Bulgaria and Turkey. In recent years, however, Syria appears to have become the main origin of such tablets. They are heavily used in Syria among the various fighting groups but also make their way to other countries in the region, inlcuding Jordania and Saudi Arabia.

NPS One major trend over the last few years has been the growing importance of NPS across the world. Between 2008 and 2015 total of 644 NPS were reported by 102 countries and territories to the UNODC early warning advisory on NPS. (This compares with 244 substances under international control; 120 under the 1961 Convention and 124 under the 1971 Convention). In 2015 75 NPS have been reported to UNODC for the first time, up from 66 in 2014. Between 2012 and 2014 most substances reported for the first time belonged to the group of synthetic cannabinoids. The data reported for 2015 showed a different pattern: 20 synthetic cathinones (stimulants) were reported for the first time, almost as many as synthetic cannabinoids (21). Moreover, 21 ‘other substances‘ were reported for the first time, including synthetic opioids (e.g. fentanyl derivatives) and sedatives (e.g. benzodiazepines). The NPS market is highly dynamic. Many new substances emerge, but data also show that several NPS reported in previous years, do not seem to be any longer on the market.

The World Drug Problem and Sustainable Development Chapter 2: The World Drug Problem and Sustainable Development

Development and drug use – the static picture National indicators show that the health impact increases with development levels But subnational indicators show that lower socioeconomic status goes hand in hand with drug use disorders…. The impact of income on drug use depends on the type of drug

Marginalization and drug use disorders Drug users are more likely to be unemployed…. Higher socioeconomic groups have a greater propensity to initiate drug use than lower socioeconomic groups, but it is the lower socioeconomic groups that pay the higher price as they are more likely to become drug dependent. … and unemployed people are more likely to be drug users

Women are a minority among drug users with: Own drug use patterns Own vulnerabilities and needs Violence Stigma Drug use in the family Suitability of continuum of care Access to treatment Youth Children

Two streams of intervention: mutually reinforcing but not blind to each other General development initiatives can counter or compound the world drug problem: - Thailand - Andean countries (1960s-70s) Need to be sensitive to vulnerabilities Drug supply reduction interventions can foster or hinder economic development Afghanistan: 2000/2001 2005 opium ban (Nangarhar) Need to be targeted but mainstreamed

Development and drug markets – the dynamic picture

Environmental impact of the drug supply chain

Violence is not a foregone conclusion of drug trafficking

Violence is not a foregone conclusion of drug trafficking What determines violence levels? Centralization Violence-targeting strategies Long-term versus short-term Related parameters: - Rule of law - Corruption

Drug law offences and imprisonment Drug law offences have not declined like other crimes. But: - Almost a third of all prisoners are on pre-trial detention - Among convicted prisoners, 18% are held for drug-related offences - Among these, less than a quarter are held for personal consumption offences Imprisonment of drug offenders has an impact on people who use drugs as well as the criminal justice system The excessive use of imprisonment for drug-related offences of a minor nature is ineffective in reducing recidivism Alternatives to imprisonment can have a positive impact on people who use drugs

Partnership

Conclusions and policy recommendations Development and countering the world drug problem have to work in symbiosis. Development initiatives need to be sensitive to drugs vulnerabilities; Response to drug problem needs to be mindful of broad development aims; AD has its rightful place as a targeted initiative which can be mainstreamed into broader development programmes. Drug policies need to: be sensitive to gender, environmentally friendly and based on scientific evidence; overcome the stigmatization of drug users; ensure that no one is left behind. Drug use and its health consequences should be prevented and treated in prisons. Heroin still requires the attention of the international community.

THANK YOU FOR YOUR ATTENTION For more information: http://www.unodc.org/